According to recent data from the Global Bipolar Cohort, only 29% of people with bipolar disorder are prescribed lithium. Despite being the "gold standard" for treating this mental health condition, we often prioritize perceptions ...
Apr 28, 2026
0
5
An international collaboration, co-led by a University of Minnesota Medical School researcher, has published a paper in Alzheimer's & Dementia synthesizing global evidence on the origins of dementia inequities in Indigenous ...
Mar 2, 2026
0
6
Stroke remains one of the leading causes of death, disability, increased economic burden and decreased quality of life around the world. Current stroke therapies are time-limited and largely focused on restoring blood flow, ...
Jun 13, 2025
0
24
Alzheimer's disease, the most common cause of dementia, is currently incurable. The current drugs available have very limited efficacy and only in mild stages of the disease. A team from the University of Barcelona has developed ...
Apr 1, 2025
0
61
CBD may hold promise as a tool to help people reduce problem drinking, according to a new study published in Alcohol: Clinical and Experimental Research.
Feb 3, 2025
0
22
A pioneering study published in the International Journal of Molecular Sciences by researchers at Durham University has revealed promising results for a new treatment targeting motor neuron disease (MND).
Oct 22, 2024
0
112
Within Tibetan medicine, the medicinal herb Terminalia chebula (T. chebula) is well-known for its extensive therapeutic properties. Its usefulness against bacteria, viruses, oxidation, inflammation, glycemia, and tumors has ...
A drug used to treat diabetes slowed the progression of motor issues associated with Parkinson's disease, a study published in the New England Journal of Medicine said Wednesday.
Apr 4, 2024
0
139
Babies affected by fetal growth restriction (FGR) have poor cardiorespiratory control; now Hudson Institute researchers have become the first to show persistent injury in the brainstem of growth-restricted fetuses as the ...
Feb 28, 2024
0
33
More than a decade of new knowledge about neurodevelopmental risk in people with congenital heart disease has changed the thinking about who is most at risk and the factors that impact neurological development, learning, ...
Feb 22, 2024
0
39
